The 52-Week Low Club
Point Therapeutics (POTP) Late stage trials of key drug on hold. Down to $.13 from $3.27. NetBank (NTBK) Online bank and mortgage company will sell some assets. Mortgage market is killing them. Drops to $.54 from 52-week high of $6.90.…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Point Therapeutics (POTP) Late stage trials of key drug on hold. Down to $.13 from $3.27.
NetBank (NTBK) Online bank and mortgage company will sell some assets. Mortgage market is killing them. Drops to $.54 from 52-week high of $6.90.
PlanetOut (LGBT) Operator of gay media says turnaround is more than a year off. Down to $.95 from 52-week high of $7.95.
Atherogenics (AGIX) Failed drug trials and bad quarter. Won’t get off the list. Cry "uncle". Down to $2.16 from 52-week high of $20.03.
CalAmp (CAMP) Wireless equipment provider says it is heading for loss next Q. Down to $4.54 from 52-week high of $10.19.
Xinhua Financial Media (XMFL) Article in Barron’s points to problems with former CFO, and some key employees resign. Stock down to $8.31 from 52-week high of $13.
Douglas A. McIntyre
Contact [email protected] for any questions or corrections.
